NEW YORK, Oct. 16, 2023 /PRNewswire/ -- The Immunohistochemistry (IHC) Market size is expected to grow by USD 1.06 billion, accelerating at a CAGR of 7.52% during the forecast period, according to Technavio's market analysis. The report forecasts the market's competitive landscape and offers information on several market companies, including: Agilent Technologies Inc., Bio Rad Laboratories Inc., Bio SB, Bio Techne Corp., Biocare Medical LLC, BioGenex Laboratories Inc., CANDOR Bioscience GmbH, Cell Signaling Technology Inc., Danaher Corp., Eagle Biosciences Inc., Elabscience Biotechnology Inc., F. Hoffmann La Roche Ltd., Lunaphore Technologies SA, Merck KGaA, Miltenyi Biotec B.V. and Co. KG, PerkinElmer Inc., Takara Holdings Inc., Thermo Fisher Scientific Inc., PHC Holdings Corp., and SAKURA SEIKI Co. Ltd. To gain access to more vendor profiles available with Technavio, buy the report!
Immunohistochemistry (IHC) Market 2023 – 2027: Company Profile:
Agilent Technologies Inc: The company offers immunohistochemistry solutions for pathology laboratories to achieve high staining quality, improved standardization, and increased efficiency, enabling the goal of increased patient safety.
This report offers an up-to-date analysis of the current market scenario, the latest trends and drivers, and the overall market environment. Read Free PDF Sample Report
Immunohistochemistry (IHC) Market 2023 – 2027: Geographical Analysis
North America is projected to make a substantial 37% contribution to the global market's growth during the forecast period. The increasing demand for immunohistochemistry tests in North America is driven by factors such as its advanced healthcare system, research capabilities, and commitment to precision medicine. Notably, countries like the US and Canada in North America have well-established infrastructure with numerous hospitals, research institutes, and clinics, which is a positive influence on the regional market's growth.
Immunohistochemistry (IHC) Market 2023 – 2027: Segmentation Analysis
The market is segmented by Application (Diagnostic application, Research application, and Forensic application), End-user (Hospitals and diagnostic laboratories, Academic and research institutes, and Others), and Geography (North America, Europe, APAC, and Rest of World (ROW)).
The diagnostic application segment is expected to experience notable expansion in the Immunohistochemistry (IHC) market growth during the forecast period. There is a growing trend of incorporating immunohistochemistry in various diagnostic fields, particularly in pathology and molecular biology. This method primarily involves pinpointing and displaying proteins or antigens within tissue samples using antibodies designed to attach to these antigens. This approach plays a crucial role in comprehending disease mechanisms, identifying biomarkers, and supporting patient diagnosis and treatment.
Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View Free PDF Sample Report
Immunohistochemistry (IHC) Market 2023 – 2027: Driver & Trend:
Driver:
- Growing global elderly population drives increased demand for immunohistochemistry.
- Escalating cancer cases worldwide stimulate research, creating a need for immunohistochemistry in studying protein expression in cancer tissue.
- WHO reports over 19 million new cancer cases and 9.9 million deaths in 2020, emphasizing the importance of understanding disease mechanisms.
- Immunohistochemistry plays a pivotal role in aiding drug discovery and development, positively impacting the market.
Trend
- Automation and digitalization in immunohistochemistry processes drive market growth.
- Automated platforms and digital pathology solutions enhance efficiency and enable remote analysis.
- Reduced human variability leads to consistent staining results and improved laboratory workflow.
- Growing adoption of automation for standardized and reliable results fuels market growth.
- These factors are expected to drive immunohistochemistry market growth during the forecast period.
Strategic alliances among market vendors are a key trend in the tyrosine kinase inhibitors market. Identify key trends, drivers, and challenges in the market. Download the sample report to gain access to this information
Related Reports:
In Vitro Diagnostics (IVD) contract Manufacturing Market: The In Vitro Diagnostics (IVD) Contract Manufacturing Market size is estimated to grow by USD 9,370.27 million at a CAGR of 11.84% between 2022 and 2027.
Recombinant Proteins Market: The recombinant proteins market size is estimated to grow at a CAGR of 9.46% between 2022 and 2027. The market size is forecast to increase by USD 650.96 million.
What are the key data covered in this immunohistochemistry market report?
- CAGR of the market during the forecast periods
- Detailed information on factors that will drive the growth of the immunohistochemistry market between 2022 and 2027.
- Precise estimation of the immunohistochemistry market size and its contribution to the market in focus on the parent market
- Accurate predictions about upcoming trends and changes in consumer behavior
- A thorough analysis of the market's competitive landscape and detailed information about vendors
- Comprehensive analysis of factors that will challenge the growth of immunohistochemistry market vendors.
TOC:
- Executive Summary
- Market Landscape
- Market Sizing
- Historic Market Sizes
- Five Forces Analysis
- Market Segmentation by Application
- Market Segmentation by End-User
- Market Segmentation by Geography
- Customer Landscape
- Geographic Landscape
- Drivers, Challenges, & Trends
- Company Landscape
- Company Analysis
- Appendix
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
![](https://rt.prnewswire.com/rt.gif?NewsItemId=CG37877&Transmission_Id=202310161701PR_NEWS_USPR_____CG37877&DateId=20231016)
Share this article